For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Leading geriatric medicine specialist encourages New Zealand GPs to recognise symptoms of early Alzheimer’s Disease in patients
Leading geriatric medicine specialist encourages New Zealand GPs to recognise symptoms of early Alzheimer’s Disease in patients
Supplied by Nutricia
Monday 18 October 2021, 10:23 AM
2 minutes to Read

Globally recognised specialist in geriatric medicine and Fellow of the Australian and New Zealand Society for Geriatric Medicine, Associate Professor Michael Woodward
New Zealand GPs are being urged to be aware of an early stage of Alzheimer’s disease as recent research helps to provide hope for diagnosed patients
Alzheimer’s disease can be managed, Around two-thirds of people with dementia have Alzheimer’s disease.1 Globally recognised specialist in geriatric medicine and Fellow of the Australian
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Alzheimer’s New Zealand website, accessed 15 September 2021: https://alzheimers.org.nz/about-dementia/what-is-dementia/
2. Soininen H, Solomon A, Visser PJ, et al.36-month LipiDiDietmultinutrient clinical trial in prodromal Alzheimer’s disease. Alzheimer’s Dement. 2020;1–12. https://doi.org/10.1002/alz.12172